Division of Internal Medicine, University Hospital Basel, Basel, Switzerland.
Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland.
Am J Case Rep. 2024 Aug 25;25:e944508. doi: 10.12659/AJCR.944508.
BACKGROUND Common causes of severely elevated transaminases, especially alanine transaminase, due to liver diseases include drug-induced liver injury and acute viral hepatitis, especially hepatitis E, which can present similarly in clinical practice. Broad differential diagnostic workup in patients with elevated transaminases is required to not overlook the possibility of hepatitis E infection. CASE REPORT We report on a 65-year-old asymptomatic man who was referred to the Emergency Department from the rehabilitation center due to markedly elevated liver transaminases. Physical examination revealed no jaundice or abdominal pain. Laboratory findings included severely elevated aspartate transaminase, alanine transaminase, and bilirubin levels. He was previously treated with imipenem/cilastatin and clindamycin for a surgical site infection of his jaw after the removal of a squamous cell carcinoma 2 weeks earlier. An ultrasound of the liver was unremarkable. Drug-induced liver injury was suspected, and all potentially hepatotoxic drugs, including antibiotics, were stopped. Due to the rapid and marked increase in liver transaminases, further tests were performed, including testing for hepatitis E. Serum anti-hepatitis E virus immunoglobulin M, immunoglobulin G antibodies, and hepatitis E virus-ribonucleic acid-polymerase chain reaction turned positive, and the diagnosis of hepatitis E was confirmed. Supportive care was applied. Liver transaminases decreased spontaneously. CONCLUSIONS The diagnostic workup in patients with markedly elevated liver transaminases and suspected drug-induced liver injury should include the screening for hepatitis E. Making the correct diagnosis is crucial given the differing treatment approaches, the implications on further therapy, and the risk of contagion of hepatitis E.
导致肝酶(尤其是丙氨酸转氨酶)显著升高的常见原因包括药物性肝损伤和急性病毒性肝炎,尤其是戊型肝炎,在临床实践中两者表现相似。对于肝酶升高的患者,需要进行广泛的鉴别诊断,以避免忽略戊型肝炎感染的可能。
我们报告了一名 65 岁的无症状男性患者,因肝酶显著升高而从康复中心转至急诊科。体格检查未发现黄疸或腹痛。实验室检查发现天冬氨酸转氨酶、丙氨酸转氨酶和胆红素水平显著升高。2 周前,他因颌面部鳞状细胞癌切除术后的手术部位感染,曾接受亚胺培南/西司他丁和克林霉素治疗。肝脏超声未见异常。怀疑为药物性肝损伤,停用了所有可能导致肝损伤的药物,包括抗生素。由于肝酶迅速而显著升高,进一步进行了检查,包括戊型肝炎检查。血清抗戊型肝炎病毒免疫球蛋白 M、免疫球蛋白 G 抗体和戊型肝炎病毒 RNA-聚合酶链反应均为阳性,确诊为戊型肝炎。给予了支持性治疗。肝酶自行下降。
对于肝酶显著升高且疑似药物性肝损伤的患者,诊断性检查应包括戊型肝炎筛查。鉴于不同的治疗方法、对进一步治疗的影响以及戊型肝炎的传染风险,正确诊断非常重要。